The treatment of cancer has undergone a significant change over recent years. Increased understanding of the cancer biology has opened the way to personalised medicine by utilising treatments more efficiently, modulating resistance and developing novel targeted therapies.
Professor Schmid considers the emerging options and associated challenges, considering the impact of epigenetics, the application of new therapies, and the change of thinking about how research is conducted to deliver personalised treatment.